LXXGF - Scientists Develop Tests to Track Skin Cancer Treatment Success
Cancer has long been a dangerous disease accounting for lots of deaths worldwide. Diagnosing and treating it has also become a big challenge because as the tumors grow, the old cancer cells are replaced by the newly formed ones. These cells then die off, releasing their DNA into the bloodstream of the patient. However, new blood tests have been developed to help in diagnosing it. The new blood test has been designed to aid in treating skin cancer and the tests have proven to be effective after a few days of drug therapy.
Researchers from the Perlmutter Cancer Center and those from the NYU School of Medicine tracked the circulating tumor DNA (“ctDNA”) for the cancer genes in blood samples of patients with stage...
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.